The bisindolylmaleimide protein kinase C inhibitor, Ro 32-2241, reverses multidrug resistance in KB tumour cells

MERRITT, J. E ; SULLIVAN, J. A ; WARR, R ; DREW, L ; KHAN, A ; WILSON, K ; MULQUEEN, M ; HARRIS, W ; BRADSHAW, D ; HILL, C. H ; RUMSBY, M

Cancer chemotherapy and pharmacology, 1999, Vol.43 (5), p.371-378 [Periódico revisado por pares]

Berlin: Springer

Texto completo disponível